In a move to help meet the healthcare industry’s growing need for effective infection prevention solutions, Medline Industries Inc. has announced a new agreement to purchase multiple cleaning and disinfectant technologies and manufacturing capabilities from Medtrol Inc.
Medtrol is a leading manufacturer of disinfectants, sanitizers and cleaners designed for use in various healthcare settings. This acquisition allows Medline to develop effective cleaning and disinfectant products to help prevent patient exposure to harmful pathogens, including Clostridium difficile.
Data from the Centers for Disease Control and Prevention (CDC) shows that every day, about one in every 20 hospitalized patients has an infection caused by medical care they received, including Influenza A, SARS, MRSA, VRE, HIV, Hepatitis A, B and C, Listeria monocytogenes, E. coli, Salmonella and Clostridium difficile spores. While most types of hospital-acquired infections (HAIs) are declining, Clostridium difficile remains at historically high levels. The CDC recommends that staff use an EPA-registered disinfectant with a Clostridium difficile spore claim in patient rooms to disinfect this harmful pathogen.
“Infection prevention is the top priority for our healthcare customers and this move will enable us to develop new and effective ways for healthcare workers to provide the best and safest care,” said Tim Abate, president of Medline’s Textiles and Environmental Services Divisions. “We now have the technology, manufacturing capabilities and expertise to create a robust and meaningful portfolio.”
The new cleaning and disinfection products will be available this summer. Applications of these solutions will be offered in the form of liquids and pre-saturated wipes.
For more information, visit www.medline.com.